PL84355B1 - - Google Patents

Download PDF

Info

Publication number
PL84355B1
PL84355B1 PL1970174663A PL17466370A PL84355B1 PL 84355 B1 PL84355 B1 PL 84355B1 PL 1970174663 A PL1970174663 A PL 1970174663A PL 17466370 A PL17466370 A PL 17466370A PL 84355 B1 PL84355 B1 PL 84355B1
Authority
PL
Poland
Prior art keywords
group
hydrogen atom
hydrogen
lower alkyl
general formula
Prior art date
Application number
PL1970174663A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL84355B1 publication Critical patent/PL84355B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Amplifiers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL1970174663A 1969-12-12 1970-12-11 PL84355B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1962497A DE1962497C3 (de) 1969-12-12 1969-12-12 Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
PL84355B1 true PL84355B1 (enExample) 1976-03-31

Family

ID=5753745

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1970144934A PL81424B1 (enExample) 1969-12-12 1970-12-11
PL1970174664A PL84354B1 (enExample) 1969-12-12 1970-12-11
PL1970174663A PL84355B1 (enExample) 1969-12-12 1970-12-11

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL1970144934A PL81424B1 (enExample) 1969-12-12 1970-12-11
PL1970174664A PL84354B1 (enExample) 1969-12-12 1970-12-11

Country Status (25)

Country Link
US (1) US3966814A (enExample)
JP (3) JPS5116420B1 (enExample)
KR (2) KR780000007B1 (enExample)
AR (2) AR194205A1 (enExample)
AT (3) AT317192B (enExample)
BE (1) BE760252A (enExample)
BG (1) BG17956A3 (enExample)
CH (1) CH556322A (enExample)
CS (3) CS151063B2 (enExample)
DE (1) DE1962497C3 (enExample)
DK (1) DK136526B (enExample)
ES (3) ES386345A1 (enExample)
FI (1) FI53301C (enExample)
FR (1) FR2081347B1 (enExample)
GB (1) GB1330188A (enExample)
HU (1) HU162736B (enExample)
IE (1) IE34807B1 (enExample)
IL (1) IL35840A (enExample)
NL (1) NL169583C (enExample)
NO (1) NO131126C (enExample)
PL (3) PL81424B1 (enExample)
RO (3) RO61063A (enExample)
SE (1) SE378101B (enExample)
SU (2) SU505349A3 (enExample)
YU (3) YU35753B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187319B1 (enExample) * 1972-06-09 1975-06-20 Bottu Exploit Labo
GB1535435A (en) * 1975-12-11 1978-12-13 Tanabe Seiyaku Co Benzyl alcohol derivatives
JPS53149940A (en) * 1977-06-02 1978-12-27 Tanabe Seiyaku Co Ltd Novel benzyl alcohol derivatives and their preparation
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
IE883400L (en) * 1987-11-13 1989-05-13 Fuisz Technologies Ltd Phenethanolamine derivatives
US5194450A (en) * 1988-04-20 1993-03-16 Burroughs Wellcome Co. Anti-hypertensive sulfonanilides
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides
ATE299489T1 (de) * 1997-08-05 2005-07-15 Pola Chem Ind Inc Aminderivate und verfahren zu ihrer herstellung
RU2426532C2 (ru) 2004-03-17 2011-08-20 Новартис Аг Применение органических соединений
AU2013202127B2 (en) * 2006-08-10 2014-06-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
MX2009001534A (es) * 2006-08-10 2009-04-08 Us Gov Health & Human Serv Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
AU2011224241B2 (en) 2010-03-10 2014-05-08 Sri International The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
JP6208031B2 (ja) * 2014-01-30 2017-10-04 東芝ライフスタイル株式会社 ブラシレスモータおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
US3135797A (en) * 1958-04-15 1964-06-02 Colgate Palmolive Co Aromatic amino antispasmodic compounds
US3139441A (en) * 1960-02-16 1964-06-30 Colgate Palmolive Co Alpha (3, 4 dihidroxy phenyl)-beta-(nu-3, 14'-methylenedioxy-phenyl)-alkylamino ethanols
NL300751A (enExample) * 1962-11-30 1900-01-01
GB1059968A (en) * 1964-01-20 1967-02-22 Ici Ltd Naphthalene derivatives
NL6401871A (enExample) * 1964-02-27 1965-08-30
GB1095378A (enExample) * 1965-06-22
DE1543372A1 (de) * 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen

Also Published As

Publication number Publication date
ES395481A1 (es) 1973-12-16
SU384229A3 (enExample) 1973-05-23
US3966814A (en) 1976-06-29
SE378101B (enExample) 1975-08-18
AR198224A1 (es) 1974-06-07
NL169583B (nl) 1982-03-01
YU35753B (en) 1981-06-30
DE1962497C3 (de) 1979-09-20
DK136526B (da) 1977-10-24
PL81424B1 (enExample) 1975-08-30
ES395482A1 (es) 1973-12-16
HU162736B (enExample) 1973-04-28
NL7018031A (enExample) 1971-06-15
CS151064B2 (enExample) 1973-09-17
FR2081347A1 (enExample) 1971-12-03
IE34807B1 (en) 1975-08-20
SU505349A3 (ru) 1976-02-28
IL35840A0 (en) 1971-02-25
CH556322A (de) 1974-11-29
JPS5138716B1 (enExample) 1976-10-23
YU137878A (en) 1981-02-28
DK136526C (enExample) 1978-03-28
NL169583C (nl) 1982-08-02
AT302284B (de) 1972-10-10
SU417936A3 (enExample) 1974-02-28
RO61063A (fr) 1978-07-15
YU137978A (en) 1981-02-28
KR780000269B1 (en) 1978-07-24
JPS5116420B1 (enExample) 1976-05-24
RO61132A (enExample) 1976-12-15
YU35868B (en) 1981-08-31
NO131126B (enExample) 1974-12-30
BE760252A (fr) 1971-06-11
ES386345A1 (es) 1974-01-01
GB1330188A (en) 1973-09-12
BG17956A3 (bg) 1974-03-05
JPS5221505B1 (enExample) 1977-06-10
IE34807L (en) 1971-06-12
FI53301C (fi) 1978-04-10
YU301070A (en) 1980-12-31
YU35867B (en) 1981-08-31
NO131126C (enExample) 1975-04-09
CS151062B2 (enExample) 1973-09-17
RO56808A (enExample) 1975-03-15
KR780000007B1 (en) 1978-03-04
CS151063B2 (enExample) 1973-09-17
DE1962497B2 (de) 1979-01-25
AR194205A1 (es) 1973-06-29
IL35840A (en) 1974-06-30
AT317192B (de) 1974-08-12
FI53301B (enExample) 1977-12-30
FR2081347B1 (enExample) 1974-08-30
AT299924B (de) 1972-07-10
PL84354B1 (enExample) 1976-03-31
DE1962497A1 (de) 1971-06-16

Similar Documents

Publication Publication Date Title
JP5670338B2 (ja) ミトコンドリアの膜透過性遷移の阻害剤として有用なアクリルアミド誘導体
DE69807349T2 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
PT94231A (pt) Processo para a preparacao de compostos de ureia antihiperlipidemicos e anti-ateroscleroticos
JPH05345752A (ja) 新規の１，２，４−トリアミノベンゼン誘導体およびその製造方法
US6514986B2 (en) Chiral fluoroquinolone arginine salt forms
CH626611A5 (enExample)
PL113208B1 (en) Process for preparing novel phthalazine derivatives
HU191643B (en) Process for preparing new n-phenyl-n'-cycloalkyl-alkanoyl-piperazine derivatives
ES2606925T3 (es) Compuesto de benzopirano deuterado y aplicación del mismo
PL119783B1 (en) Process for preparing novel phenethanoloamines
BRPI0712483A2 (pt) sais de ácido clorìdrico de 6-metóxi-8-[4-1-(5-flúor)-quinolin-8-il-piperidin-4-il)-pip erazin-1-il]-quinolina
US4320148A (en) 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
PL96308B1 (pl) Sposob wytwarzania nowych fenyloalkiloamin
HU185676B (en) Process for preparing new phenyl-alkyl-amines
JPS6289649A (ja) 抗痙れん薬およびその製剤
PL81424B1 (enExample)
EP1311506B1 (en) Chiral fluoroquinolizinone arginine salt forms
PT99563B (pt) Processo para a preparacao de aminas biologicamente activas
JPH05247069A (ja) アミノアルカンホスフィン酸およびその塩
PT90986B (pt) Processo para a preparacao de esteres de estramustina e de composicoes farmaceuticas que os contem
DE2325633A1 (de) Piperazinderivate
DE2656088C2 (de) Benzylalkoholderivate, Verfahren zu deren Herstellung und pharmazeutisches Mittel auf deren Basis
BRPI0713107A2 (pt) sais de siccinato de 6-metoxi-8-[4-(1-(5-flúor)-quinolin-8-ila-piperidin-4-ila)- piperazin-1-ila]-quinolina, e formas cristalinas destes
JPH0285241A (ja) 気管支拡張活性を有する化合物
AU2006252540A1 (en) MAO-B inhibitors useful for treating obesity